false
English
Catalog
2023 World Conference on Lung Cancer (Posters)
P2.13. Pathological Images Machine Learning Predic ...
P2.13. Pathological Images Machine Learning Predicts Long Term Effects for Immunotherapy in Small-Cell Lung Cancer - PDF(Slides)
Back to course
Pdf Summary
Researchers from Wakayama Medical University in Japan have developed a machine learning model that predicts the efficacy of immunotherapy in small-cell lung cancer (SCLC) using pathological images. The study suggests that the tumor immune microenvironment (TIME) could be a promising biomarker for immunotherapy in SCLC. However, objectively evaluating the complex interaction of various inflammatory and tumor cells within TIME is challenging for humans. Machine learning has emerged as a potential solution for precise and objective spatial analysis.<br /><br />The predictive model developed in the study is a two-class classifier that predicts 365-day progression-free survival. The primary endpoint of the model is the area under the curve (AUC) of the pathological image model. The secondary endpoints include the AUC of the patient information model and the combined model, as well as progression-free survival and the interpretative importance of variables for determining long-term efficacy.<br /><br />The researchers collected patient information, such as metastatic site and blood test results, and used hematoxylin and eosin staining, programmed death-ligand 1 expression, and multiplex immunofluorescence (CD8 and FoxP3) to analyze the biomarkers in the PATHOLOGICAL IMAGES of patients. They employed a patch-based classifier and a feature extraction module to extract features from the images and predict long-term efficacy.<br /><br />The study demonstrates that a machine learning analysis of TIME in pathological images can accurately predict the long-term efficacy of immunotherapy in SCLC. The researchers also found that certain patient information, such as age and presence of metastasis, played a significant role in determining the efficacy of immunotherapy.<br /><br />These findings provide valuable insights into the potential use of machine learning models in predicting the effectiveness of immunotherapy in SCLC patients. Further research in this area could help improve patient outcomes and personalize treatment approaches. The study was funded by Chugai Pharmaceutical Co., Ltd.<br /><br />In conclusion, a machine learning model using pathological images can predict the efficacy of immunotherapy in small-cell lung cancer. This approach provides an objective and precise analysis of the tumor immune microenvironment, which could aid in determining the effectiveness of immunotherapy in SCLC patients.
Asset Subtitle
Ryota Shibaki
Meta Tag
Speaker
Ryota Shibaki
Topic
SCLC & Neuroendocrine Tumors: Biomarkers & Radiomics
Keywords
Wakayama Medical University
machine learning model
immunotherapy
small-cell lung cancer
predict
pathological images
tumor immune microenvironment
biomarker
spatial analysis
progression-free survival
×
Please select your language
1
English
5
普通话
11
Dutch